Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

New England Journal of Medicine

Volumn 339, Issue 14, 1998, Pages 953-959

  Ristow, Michael ^a,b   Müller Wieland, Dirk ^b   Pfeiffer, Andreas ^c   Krone, Wilhelm ^b   Kahn, C Ronald ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CELL DIFFERENTIATION; FEMALE; GENE CONTROL; GENE MUTATION; GENE OVEREXPRESSION; GERMANY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS;

ADIPOCYTES; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MIDDLE AGED; MUTATION; OBESITY; PHOSPHORYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SERINE; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0032189782     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199810013391403     Document Type: Article

References (29)

1. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med 1997;337: 396-407.
2. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-11.
3. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993;270:2207-12.
4. Bouchard C, ed. Genetics of obesity. Boca Raton, Fla.: CRC Press, 1994.
5. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-73.
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32. [Erratum, Nature 1995;374:479.]
7. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-71.
8. Flier JS, Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998;92:437-40.
9. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
10. Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392: 398-401.
11. Spiegelman BM, Flier JS. Adipogenesis: rounding out the big picture. Cell 1996;87:377-89.
12. Latruffe N, Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie 1997;79:81-94.
13. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994;79:1147-56. [Erratum, Cell 1995;80:957]
14. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 1996;274:2100-3.
15. Adams M, Reginato MJ, Shao DL, Lazar MA, Chatterjee VK. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 1997;272:5128-32.
16. Ristow M, Giannakidou E, Hebinck J, et al. An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes 1998;47:851-4.
17. Ristow M, Vorgerd M, Möhlig M, Schatz H, Pfeiffer A. Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance. J Clin Invest 1997;100:2833-41.
18. Ristow M, Möhlig M, Rifai M, Schatz H, Feldmann K, Pfeiffer A. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 1995;346: 502-3.
19. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990;18:3587-96.
20. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 1993;90:8392-6.
21. Brüning JC, Winnay J, Cheatham B, Kahn CR. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 1997;17:1513-21.
22. Knebel B, Kellner S, Kotzka J, et al. Defects of insulin and IGF-1 action at receptor and postreceptor level in a patient with type A syndrome of insulin resistance. Biochem Biophys Res Commun 1997;234:626-30.
23. Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997;241:270-4.
24. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270:12953-6.
25. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996;45:1661-9.
26. Schwartz S, Raskin P, Fonseca V, Graveline JF. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. N Engl J Med 1998;338:861-6.
27. Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101:1354-61.
28. Kahn CR. Banting Lecture: insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994;43:1066-84.
29. National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 1995. (NIH publication no. 95-1468.)